TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of ...

Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...

Evergy Q4 2025 presentation: data centers and $21.6B investment plan to drive 6-8%+ EPS growth ...

AI-assisted code speeds development, but introduces vulnerabilities at an alarming rate. Waratek IAST reports flaws ...

SAN JOSE, CA, UNITED STATES, February 24, 2026 /EINPresswire.com/ — TapClicks, the leader in Smart Marketing solutions, today announced the launch of SmartStory, a ...

SAN JOSE, CA, UNITED STATES, February 24, 2026 / EINPresswire.com / — TapClicks, the leader in Smart Marketing solutions, today announced the launch of SmartStory, a new AI-powered solution that ...

Presenting ten abstracts including observations on long-term safety, disease progression, and decline in muscle contractile area with givinostat Encore oral presentation also highlights analyses from ...

Preview this article 1 min If the company moves forward with the project on a 186-acre site, it could entail more than $1 billion in investment in a growing area of Fort Worth. Get the latest in this ...

Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in ...

BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today ...